Paxlovid 2.0: Next generation of COVID antiviral hits final human trials
COVID antiviral Paxlovid wasn't perfect. Many patients couldn't take it due to extreme side effects but now the second generation of antivirals are on the way and they promise better efficacy and fewer drug complications. Source of Article